MyFinsight
Home
Blog
About
Back
Cash Flow
Telomir Pharmaceuticals, Inc. (TELO)
Telomir Pharmaceuticals, Inc. (TELO)
source: myfinsight.com
something is missing
$3,000,000
Net proceeds from
sale of common stock...
$6,311
Net cash provided by
financing activities
$622,107
(-40.63%↓ Y/Y)
Canceled cashflow
$2,384,204
Net change in cash
-$390,225
(23.76%↑ Y/Y)
Canceled cashflow
$622,107
Stock-based compensation
expense stock option...
$587,737
Stock-based compensation
expense
$198,734
(-96.71%↓ Y/Y)
Prepaid expenses
-$33,406
(-291.83%↓ Y/Y)
Proceeds from teli
contribution, related party
-$2,000,000
Repayment of payable to
related party
$317,708
Repayments on insurance
loan payable
$66,496
Net cash used in
operating activities
-$1,012,332
(35.09%↑ Y/Y)
Canceled cashflow
$819,877
Net loss
-$1,721,528
Trade accounts
payable and accrued...
-$84,089
(74.72%↑ Y/Y)
Back